In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

Biography

Fethi Trabelsi, PhD

Director, Scientific and Regulatory Affairs, Anapharm
5160 boul. Decarie, 8th Floor
Montreal, Quebec
H3X 2H9 CANADA
Tel: 514 484 7513
Fax: 515 485 7501

E-mail: ftrabelisi@anapharm.com

Expertise: Pharmacokinetics and protocol design

 

Dr. Trabelsi has more than 8 years of experience in contract research, mainly in pharmacokinetics and protocol-design development for early stage programs. Before joining the pharmaceutical industry, Dr. Trabelsi taught physiology at the University of Montreal for more than 8 years. He currently lectures in pharmaceutical courses at the University Laval. Dr. Trabelsi has published numerous scientific papers in peer-review journals and presented in many national and international scientific symposiums and conferences. He is a member of many scientific associations including the Drug Information Association (DIA), the Generic Pharmaceutical Association (GPhA), and the Canadian Generic Pharmaceutical Association (CGPA). He frequently interacts with key scientists and regulators at FDA, TPD, and EU agencies.

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390